免疫检测市场规模、份额和成长分析：按产品类型、技术、生物标记类型、应用、最终用户和地区划分－2026-2033年产业预测

2024年全球免疫检测市场价值为32亿美元，预计2025年将成长至34.2亿美元，2033年将成长至58.8亿美元。预测期（2026-2033年）的复合年增长率预计为7.0%。

神经免疫免疫检测市场专注于测量对中枢神经系统疾病诊断至关重要的免疫学和神经学标记的检测方法。随着神经退化性疾病疾病和神经发炎性疾病的日益普遍，对早期和微创诊断工具的需求也日益增长。从单分析物ELISA到包括超灵敏数位检测在内的先进多重检测平台的演变，显着提高了检测低浓度分析物的能力。这项进步凸显了迫切的临床需求，并推动了诊断公司和生物製药合作伙伴的投资。技术灵敏度是关键的成长要素，它能够提高检测性能并扩大应用范围。人工智慧尤其在推动市场成长和融入常规临床实践方面发挥着至关重要的作用，它能够提高诊断准确性、规范品质检查并实现更快、更可靠的临床决策。

推动全球神经免疫免疫检测市场发展的因素

全球神经免疫学检测市场的发展主要得益于检测灵敏度、特异性和多重检测能力的显着提升。这些改进增强了对各种检体类型和疾病状态下神经免疫生物标记的检测能力，从而能够更早、更准确地识别神经系统免疫反应。此外，製造商在试剂化学和检测平台方面也不断创新，提高了临床应用的可靠性，并拓展了检测在研究和诊断领域的应用范围。这种技术进步降低了使用门槛，并透过开发专门针对神经发炎和神经退化性疾病研究的新型检测方法和工作流程，推动了市场成长，最终促进了实验室和临床医生对这些检测方法的广泛应用。

全球神经免疫学检测市场的限制因素

全球神经免疫学检测市场面临严峻挑战，主要原因是检测方法的开发、临床检验以及符合监管标准都需要大量投资。这些资金和时间上的障碍对小规模实验室和新兴製造商的影响尤其显着，它们往往难以应对漫长的开发流程和合规要求。因此，市场竞争减弱，新产品上市延迟，市场上可供选择的免疫检测方法种类有限。儘管医疗机构对神经免疫学诊断的兴趣和需求日益增长，但这种资金负担阻碍了产品系列的快速扩张，并延缓了这些诊断工具在临床实践中的应用。

全球免疫检测分析市场趋势

全球神经免疫学检测市场的一个显着趋势是其向照护现场检测（POC​​T）领域的扩展。这些先进诊断工具的应用正从中心检查室转向诊所和社区医疗机构。这一转变的主要驱动力是人们对及时、可操作的生物标记资讯的需求日益增长，这对于改善患者照护和加快治疗决策至关重要。简化平台和携带式设备的开发使临床医生能够在患者附近进行检测，并将这些评估有效地整合到现有的临床工作流程和电子健康记录中。诊断服务的可近性提高促进了跨学科合作，并推动了专为门诊环境设计的便捷检测方法的创新。因此，神经免疫学检测正逐渐成为现代医疗保健服务的核心要素。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球免疫检测市场规模：依产品类型及复合年增长率划分（2026-2033 年）

• 试剂和试剂盒
  • 酵素免疫分析法试剂
  • 蛋白质印迹试剂盒
  • 多重检测试剂盒
• 分析器
  • 自动免疫检测装置
  • 照护现场免疫检测装置
  • 高通量免疫检测分析仪

全球免疫检测市场规模：依技术及复合年增长率划分（2026-2033 年）

• 免疫测量（RIA）
• 聚合酵素链锁反应（PCR）
• 酵素免疫分析法（ELISA）
• 西方墨点法
• 快速检测
• 酵素介导免疫测定法（ELISPOT）

全球免疫检测市场规模：按生物标记类型和复合年增长率划分（2026-2033 年）

• β-淀粉样蛋白（AB）
• Tau蛋白（磷酸化Tau）
• α-突触核蛋白（α-syn）
• 神经丝轻链（NfL）
• 自体抗体
• 细胞激素
• 胶质纤维酸性蛋白（GFAP）
• 神经元特异性烯醇化酶（NSE）
• 泛素C端水解酵素L1（UCH-L1）
• 脑源性神经营养因子（BDNF）

全球免疫检测市场规模：依应用及复合年增长率划分（2026-2033 年）

• 阿兹海默症
• 帕金森氏症（PD）
• 亨丁顿舞蹈症
• 肌萎缩侧索硬化症（ALS）
• 脊髓性肌肉萎缩症（SMA）

全球免疫检测市场规模：依最终用户和复合年增长率划分（2026-2033 年）

• 医院
• 诊所
• 学术机构
• 生物製药公司
• 製药公司
• 其他最终用户

全球免疫检测市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Bio-Rad Laboratories Inc.
• GenScript Biotech Corporation
• Abcam plc
• BioLegend Inc.
• Meso Scale Diagnostics LLC
• Sino Biological Inc.
• Quanterix Corporation
• Cusabio Technology LLC
• OriGene Technologies Inc.
• Elabscience Biotechnology Inc.
• RayBiotech Life Inc.
• Enzo Life Sciences Inc.
• Rockland Immunochemicals Inc.
• Assay Genie Ltd.
• Novus Biologicals LLC
• Creative Diagnostics
• MyBioSource Inc.
• Immuno-Biological Laboratories Co. Ltd.
• Boster Biological Technology
• Cloud-Clone Corp.
• FineTest Biotech Inc.
• Abbexa Ltd.

结论与建议

Global Neuro Immunoassay Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.42 Billion in 2025 to USD 5.88 Billion by 2033, growing at a CAGR of 7.0% during the forecast period (2026-2033).

The neuro immunoassay market focuses on assays that measure immune and neuronal biomarkers crucial for diagnosing central nervous system disorders. The increasing prevalence of neurodegenerative and neuroinflammatory diseases has heightened the demand for early and minimally invasive diagnostic tools. The evolution from single-analyte ELISAs to advanced multiplex platforms, including ultra-sensitive digital assays, has significantly improved detection capabilities for low-abundance analytes. This progress underscores the urgent clinical need driving investments from diagnostics firms and biopharma partners. Technological sensitivity is a key growth factor, enhancing assay performance and expanding applications. Notably, artificial intelligence plays a pivotal role by improving diagnostic accuracy, standardizing quality checks, and enabling quicker, more reliable clinical decisions, thereby propelling market growth and integration into routine care pathways.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuro Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuro Immunoassay Market Segments Analysis

Global neuro immunoassay market is segmented by product type, technology, biomarker type, application, end-user and region. Based on product type, the market is segmented into Reagents And Kits and Analyzers. Based on technology, the market is segmented into Radioimmunoassays (RIA), Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Rapid Tests and Enzyme-Linked Immunospot Assay (ELISPOT). Based on biomarker type, the market is segmented into Amyloid-Beta (AB), Tau Protein (p-Tau), Alpha-Synuclein (a-syn), Neurofilament Light Chain (NfL), Autoantibodies, Cytokines, Glial Fibrillary Acidic Protein (GFAP), Neuron-Specific Enolase (NSE), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) and Brain-Derived Neurotrophic Factor (BDNF). Based on application, the market is segmented into Alzheimer's Disease, Parkinson's Disease (PD), Huntington's Disease, Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA). Based on end-user, the market is segmented into Hospitals, Clinics, Academic Organizations, Biopharmaceutical Companies, Pharmaceutical Companies and Other End-Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neuro Immunoassay Market

The Global Neuro Immunoassay market is driven by significant advancements in assay sensitivity, specificity, and multiplexing capabilities, which enhance the detection of neuroimmune biomarkers across various sample types and disease conditions. These improvements facilitate earlier and more precise identification of neurological immune responses. Additionally, manufacturers are innovating reagent chemistry and detection platforms, boosting clinical confidence and expanding applications in both research and diagnostics. This technological evolution lowers usage barriers, promoting market growth by enabling the development of new assay formats and workflows tailored for neuroinflammatory and neurodegenerative research, ultimately leading to increased adoption among laboratories and clinicians.

Restraints in the Global Neuro Immunoassay Market

The Global Neuro Immunoassay market faces significant challenges due to the substantial investments needed for assay development, clinical validation, and adherence to regulatory standards. These financial and temporal barriers disproportionately impact smaller laboratories and emerging manufacturers, which often struggle to navigate lengthy development processes and certification requirements. As a result, competition is diminished, and the introduction of new products is delayed, limiting the availability of diverse neuro immunoassays in the market. This economic strain hinders rapid portfolio expansion and slows the integration of these diagnostic tools into clinical practices, despite a growing interest and demand for neuroimmune diagnostics among healthcare providers.

Market Trends of the Global Neuro Immunoassay Market

The Global Neuro Immunoassay market is witnessing a significant trend towards point-of-care expansion, with the adoption of these advanced diagnostic tools moving from central laboratories to clinics and community settings. This shift is primarily driven by the growing demand for timely and actionable biomarker information, which is essential for improving patient care and facilitating early treatment decisions. The development of simplified platforms and portable instruments enables clinicians to conduct tests closer to patients, effectively integrating these assessments into existing clinical workflows and electronic health records. Enhanced access to diagnostic services promotes collaboration across specialties and fuels innovation in user-friendly assays designed specifically for outpatient environments, positioning neuro immunoassays as a pivotal component in modern healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Neuro Immunoassay Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Reagents And Kits
  • Enzyme Linked Immunosorbent Assay Reagents
  • Western Blotting Kits
  • Multiplex Assay Kits
• Analyzers
  • Automated Immunoassay Analysers
  • Point Of Care Immunoassay Analysers
  • High Throughput Immunoassay Analysers

Global Neuro Immunoassay Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Radioimmunoassays (RIA)
• Polymerase Chain Reaction (PCR)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Western Blot
• Rapid Tests
• Enzyme-Linked Immunospot Assay (ELISPOT)

Global Neuro Immunoassay Market Size by Biomarker Type & CAGR (2026-2033)

• Market Overview
• Amyloid-Beta (AB)
• Tau Protein (p-Tau)
• Alpha-Synuclein (a-syn)
• Neurofilament Light Chain (NfL)
• Autoantibodies
• Cytokines
• Glial Fibrillary Acidic Protein (GFAP)
• Neuron-Specific Enolase (NSE)
• Ubiquitin C-Terminal Hydrolase L1 (UCH-L1)
• Brain-Derived Neurotrophic Factor (BDNF)

Global Neuro Immunoassay Market Size by Application & CAGR (2026-2033)

• Market Overview
• Alzheimer's Disease
• Parkinson's Disease (PD)
• Huntington's Disease
• Amyotrophic Lateral Sclerosis (ALS)
• Spinal Muscular Atrophy (SMA)

Global Neuro Immunoassay Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Academic Organizations
• Biopharmaceutical Companies
• Pharmaceutical Companies
• Other End-Users

Global Neuro Immunoassay Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Biomarker Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Technology, Biomarker Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Biomarker Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Biomarker Type, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Biomarker Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meso Scale Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanterix Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cusabio Technology LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elabscience Biotechnology Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech Life Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland Immunochemicals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Assay Genie Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus Biologicals LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyBioSource Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immuno-Biological Laboratories Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boster Biological Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cloud-Clone Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FineTest Biotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbexa Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations